CHILD’S NAME:
LIFE-THREATENING ALLERGIES & AUVI-Q
ALLERGIC TO:
CLOSEST AUVI-Q LOCATION:
EMERGENCY CONTACT:
Indication
AUVI-Q® (epinephrine injection, USP) is a prescription medicine used to treat life-threatening allergic reactions,
including anaphylaxis, in people who are at risk for or have a history of serious allergic reactions.
Please see additional Important Safety Information throughout, and enclosed full Prescribing Information and
Patient Information, or at [Link].
Be informed, be prepared.1
This guide has information that can help when caring for someone with life-threatening allergies.
3 things to know about anaphylaxis
1
It’s life-threatening.
Anaphylaxis is a severe allergic reaction. It could happen seconds or minutes
after exposure.
It’s treated with epinephrine.
Anaphylaxis requires treatment with epinephrine right away. Antihistamines do
not act quickly enough to treat anaphylaxis.
After the injection, call 911.
It’s important to seek medical help, even if the person who experienced anaphylaxis
feels better.
Important Safety Information
AUVI-Q is for immediate self (or caregiver) administration and does not take the place of emergency
medical care. Seek immediate medical treatment after using AUVI-Q. Each AUVI-Q contains a
single dose of epinephrine. AUVI-Q should only be injected into your outer thigh, through clothing if
necessary. If you inject a young child or infant with AUVI-Q, hold their leg firmly in place before and
during the injection to prevent injuries. Do not inject AUVI-Q into any other part of your body, such as
into veins, buttocks, fingers, toes, hands, or feet. If this occurs, seek immediate medical treatment and
make sure to inform the healthcare provider of the location of the accidental injection. Only a healthcare
provider should give additional doses of epinephrine if more than two doses are necessary for a single
allergic emergency.
2
What anaphylaxis looks like1,2
The following are signs and symptoms of anaphylaxis.
3
4
1 BRAIN 2 FACE 3 BREATHING
• Feeling of “doom” • Swelling of lips • Shortness of breath
• Confusion or tongue that • Wheezing or coughing
• Agitation bother breathing • Tight or hoarse throat
• Trouble swallowing
4 CIRCULATION 5 STOMACH 6 SKIN
• Weak pulse • Vomiting Hives or redness
• Fainting or dizziness • Diarrhea over body
• Pale or bluish skin color
Anaphylaxis can be life-threatening. If in doubt, give epinephrine.
3
What to do when you notice anaphylaxis1
1. Inject epinephrine immediately!
Waiting can make matters worse.
2.
Call 911. Tell dispatcher the person is experiencing anaphylaxis and may need
more epinephrine.
3.
Lay the person flat, raise legs, and keep warm. If breathing is difficult or they
are vomiting, have them lie on their side or sit up.
4.
If symptoms do not improve or come back, you may inject a second dose of
epinephrine about 5 minutes after the last dose.
5. Alert emergency contacts.
6.
Get person to the ER, even if the person starts to feel better.
Note: Any more than two sequential doses of epinephrine should only be administered
under direct medical supervision.
See how to inject AUVI-Q: [Link]/Training.
Important Safety Information (cont’d)
Rarely, patients who use AUVI-Q may develop infections at the injection site within a few days of an
injection. Some of these infections can be serious. Call your healthcare provider right away if you have any
of the following symptoms at an injection site: redness that does not go away, swelling, tenderness, or the
area feels warm to the touch.
If you have certain medical conditions, or take certain medicines, your condition may get worse or you
may have more or longer lasting side effects when you use AUVI-Q. Be sure to tell your healthcare
provider about all the medicines you take, especially medicines for asthma. Also tell your healthcare
provider about all of your medical conditions, especially if you have asthma, a history of depression,
thyroid problems, Parkinson’s disease, diabetes, heart problems or high blood pressure, have any other
medical conditions, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed.
Epinephrine should be used with caution if you have heart disease or are taking certain medicines that can
cause heart-related (cardiac) symptoms.
4
How to administer AUVI-Q
Step 1
Pull AUVI-Q up from the outer case.
Step 2
Pull red safety guard down and off of AUVI-Q.
To reduce the chance of an accidental injection, do not touch the base of
the auto-injector, which is where the needle comes out. If an accidental
injection happens, get medical help right away.
Step 3
Place black end of AUVI-Q against the middle of the outer thigh, then
push firmly until you hear a click and hiss sound, and hold in place for
2 seconds.
If you are administering AUVI-Q to a young child or infant, hold the
leg firmly in place while administering an injection.
AUVI-Q can inject through clothing, if necessary. ONLY inject into the
middle of the outer thigh.
The voice instructions will indicate the injection is complete, AUVI-Q will
beep, and the lights will blink red.
Step 4
Seek emergency medical attention immediately after use, as AUVI-Q is
not a replacement for definitive medical care.
Watch the training video
Scan QR code to watch training video.
Visit [Link] for information on life-threatening allergies, anaphylaxis, and how to inject AUVI-Q.
Important Safety Information (cont’d)
Common side effects include fast, irregular or ‘pounding’ heartbeat, sweating, shakiness, headache,
paleness, feelings of over excitement, nervousness, or anxiety, weakness, dizziness, nausea and vomiting,
or breathing problems. These side effects usually go away quickly, especially if you rest. Tell your
healthcare provider if you have any side effect that bothers you or that does not go away.
Please see enclosed full Prescribing Information and Patient Information, or at [Link].
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit [Link]/medwatch or call 1-800-FDA-1088.
References: 1. Campbell RL, Kelso, JM. Anaphylaxis: Emergency treatment. UpToDate. Updated January 30, 2020. Accessed March 11, 2021. https://
[Link]/contents/anaphylaxis-emergency-treatment?search=anaphylaxis-emergency-treatment. 2. Lieberman P, Nicklas RA, Randolph C, et
al. Anaphylaxis—a practice parameter update 2015. Ann Allergy Asthma Immunol. 2015;115(5):341-384.
AUVI-Q® and AUVI-q® are registered trademarks of kaleo, Inc. © 2021 kaleo, Inc. CM-US-AQ-1907
